Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Acumen, and Latham & Watkins advised the underwriters. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced the pricing of an upsized underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Zentalis in the offering, and Cooley represented the underwriters. Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) announced the pricing of an underwritten offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises the underwriters on US$150 million offering by U.S. Physical Therapy. U.S. Physical Therapy, Inc. has announced that it has priced an underwritten...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents The Vita Coco Company, Inc. in upsized secondary offering of common stock by selling stockholder. The Vita Coco Company, Inc., a leading...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents L Catterton in the transaction. L Catterton has announced a strategic partnership with Hunter Point Capital. HPC has made a passive minority investment...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Rivian on the offering. Rivian Automotive, Inc. (Nasdaq: RIVN), announced the pricing of its offering of $1,300,000,000 aggregate principal amount of 4.625%...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison advised Driven Brands Holdings Inc. and selling stockholders Driven Equity LLC and RC IV Cayman ICW Holdings LLC, while Latham...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
You must be a Standard 1 Year member to access this content.
